Anwar, K., Sanjaya, S., Ayu, R. and Sani, F. 2026. Safety and Efficacy of Subretinal AAV-CRISPR/Cas9 Gene Editing for Rhodopsin-Mutant Retinitis Pigmentosa: A Phase I/IIa Dose-Escalation Triall. Sriwijaya Journal of Ophthalmology. 8, 2 (Jun. 2026), 478-485. DOI:https://doi.org/10.37275/sjo.v8i2.137.